Dr. Sander Piersma
Dr. Sander Piersma started as research scientist in the OncoProteomics Lab in may 2016. He is responsible for the Q-Exactive LC-MS infrastructure, method development and implementation. His research interests are in protein modification and signal transduction, and includes (clinical) phosphoproteomics method development, construction of lab tools, and signaling data analysis. Novel developments include implementation of data-independent acquisition methods for both protein expression analysis and phosphoproteomics.